The eliquis lawsuit is one of the biggest pharmaceutical cases moving through courts in 2026. Thousands of patients claim the blood thinner caused life-threatening bleeding events.
Bristol Myers Squibb and Pfizer face allegations they hid serious risks. They allegedly failed to warn doctors and patients about uncontrollable bleeding.
This article breaks down settlement amounts, eligibility rules, and filing deadlines. You will also find the latest MDL updates and compensation tiers.
Over 10,000 claims have been filed in federal court so far. That number keeps growing as more patients come forward.
Eliquis Lawsuit 2026
The eliquis lawsuit in 2026 is active and still accepting new claims. Federal courts are processing cases through the existing MDL structure.
The litigation centers on allegations that Eliquis causes severe bleeding. Plaintiffs argue the drug makers downplayed these risks for years.
Courts in the Southern District of New York oversee most of these cases. Judge Denise Cote has managed the docket since consolidation.
Bellwether trial preparations are underway as of early 2026. These test trials will shape settlement negotiations going forward.
| Detail | Info |
|---|---|
| Case Status | Active MDL |
| Court | Southern District of New York |
| Total Claims | Over 10,000 |
| Next Major Event | Bellwether trials |
Patients who took Eliquis and suffered bleeding should act now. The window to join the litigation may narrow later this year.
Eliquis Lawsuit Settlement Amounts
Eliquis lawsuit settlement amounts in 2026 range from $25,000 to over $500,000 per claim. The exact figure depends on injury severity.
No global settlement has been announced yet. Individual case values vary based on medical records and documented harm.
Wrongful death claims typically command the highest payouts. Surviving family members may receive amounts at the top of the range.
| Injury Tier | Estimated Settlement Range |
|---|---|
| Minor bleeding event | $25,000 to $75,000 |
| Hospitalization required | $75,000 to $200,000 |
| Permanent disability | $200,000 to $400,000 |
| Wrongful death | $400,000 to $500,000+ |
These figures are estimates based on similar pharmaceutical cases. Actual payouts will depend on final settlement agreements or trial verdicts.
Key Takeaway: Settlement amounts vary widely based on injury severity, with wrongful death claims reaching $500,000 or more.
Eliquis Lawsuit Update
The latest eliquis lawsuit update shows the MDL is moving toward trial. Pretrial motions and discovery are largely complete as of 2026.
Both sides have exchanged thousands of internal company documents. These records allegedly show Bristol Myers Squibb knew about bleeding risks early.
Plaintiff attorneys are pushing for a global settlement this year. Defense lawyers continue to contest liability in individual cases.
Several state court cases are also progressing in parallel. California and New Jersey courts have active Eliquis dockets.
- Discovery phase is substantially complete
- Bellwether trial dates are being scheduled
- Settlement talks are reportedly ongoing
- New plaintiff filings continue monthly
The next six months could bring major developments. A bellwether verdict would set the tone for all remaining cases.
Eliquis Lawsuit Eligibility
Eliquis lawsuit eligibility requires proof that you took the drug and suffered a bleeding injury. You must also show the injury occurred within a specific timeframe.
Most qualifying claims involve patients who took Eliquis between 2012 and 2024. The drug was first approved by the FDA in 2012.
You need medical records documenting your bleeding event. Hospital records, doctor notes, and lab results all strengthen your claim.
| Eligibility Factor | Requirement |
|---|---|
| Drug Used | Eliquis (apixaban) |
| Timeframe | 2012 to 2024 |
| Injury Type | Severe bleeding event |
| Documentation | Medical records required |
| Age | 18 or older at time of use |
Family members of deceased patients can also file claims. Wrongful death eligibility follows similar documentation requirements.
Key Takeaway: To qualify, you must prove you took Eliquis and suffered a documented bleeding injury between 2012 and 2024.
Eliquis Blood Thinner Lawsuit
The eliquis blood thinner lawsuit targets two of the largest drug companies in the world. Bristol Myers Squibb and Pfizer co-market the drug globally.
Eliquis belongs to a class of drugs called factor Xa inhibitors. These newer blood thinners were marketed as safer than warfarin.
Plaintiffs argue that marketing claims were misleading. They say the companies minimized the risk of uncontrolled bleeding.
Unlike warfarin, Eliquis initially had no approved reversal agent. This meant doctors had limited options during bleeding emergencies.
- Eliquis was approved by the FDA in December 2012
- Annual sales exceeded $12 billion by 2023
- It is prescribed for atrial fibrillation and blood clot prevention
- Over 20 million patients have used the drug worldwide
The sheer scale of Eliquis use makes this one of the largest drug injury cases in recent memory. Think of it like the Vioxx litigation of the early 2000s but with even more plaintiffs.
Eliquis Bleeding Lawsuit
The eliquis bleeding lawsuit focuses on one core allegation. The drug causes dangerous and sometimes fatal bleeding episodes.
Plaintiffs report gastrointestinal bleeding as the most common injury. Intracranial hemorrhage and retroperitoneal bleeding are also frequent claims.
Bleeding events often occurred without warning signs. Many patients had no prior history of bleeding disorders.
| Bleeding Type | Frequency in Claims |
|---|---|
| Gastrointestinal | Most common |
| Intracranial | Second most common |
| Retroperitoneal | Less common but severe |
| Ocular hemorrhage | Rare but documented |
Emergency room records often form the backbone of these claims. The sudden nature of the bleeding is a key argument for plaintiffs.
Doctors testified in depositions that they would have chosen different drugs. They say adequate warnings would have changed their prescribing decisions.
Key Takeaway: Gastrointestinal and intracranial bleeding are the most common injuries driving Eliquis litigation.
Eliquis Lawsuit Filing Deadline
The eliquis lawsuit filing deadline varies by state due to statute of limitations rules. Most states allow two to three years from the date of injury.
Some states use a “discovery rule” for pharmaceutical cases. This means the clock starts when you learned the drug caused your injury.
Federal MDL rules may extend certain deadlines for consolidated cases. Your attorney can confirm whether your claim is still timely.
| State | Statute of Limitations |
|---|---|
| New York | 3 years |
| California | 2 years |
| Texas | 2 years |
| Florida | 4 years |
| New Jersey | 2 years |
Waiting too long can permanently bar your claim. Courts strictly enforce these deadlines with very few exceptions.
If you suffered a bleeding event in 2023 or later, you likely still have time. Older claims need immediate legal review to confirm eligibility.
Eliquis Side Effects Lawsuit
The eliquis side effects lawsuit alleges the drug label was inadequate. Plaintiffs say the warning information failed to convey the true bleeding risk.
Common side effects listed on the label include minor bruising. But plaintiffs experienced far more severe reactions than the label suggested.
The FDA has received thousands of adverse event reports for Eliquis. Many of these reports describe life-threatening hemorrhagic events.
- Uncontrolled nosebleeds lasting hours
- Blood in urine or stool
- Coughing up blood
- Severe headaches indicating brain bleeding
- Unexplained swelling and pain in the abdomen
The gap between listed side effects and real-world outcomes is central to the case. Plaintiffs argue this gap proves the companies withheld critical safety data.
Internal emails obtained during discovery allegedly support this theory. They suggest company scientists raised concerns that marketing teams dismissed.
Key Takeaway: The lawsuit argues Eliquis warning labels severely understated the risk of major bleeding events.
Eliquis Internal Bleeding Lawsuit
The eliquis internal bleeding lawsuit covers some of the most severe claims. Internal bleeding is harder to detect and often more dangerous than external bleeding.
Gastrointestinal hemorrhage is the leading internal bleeding claim. Patients describe sudden, severe abdominal pain followed by hospitalization.
Some plaintiffs required emergency surgery to stop the bleeding. Others needed multiple blood transfusions over several days.
| Internal Bleeding Type | Typical Outcome |
|---|---|
| GI hemorrhage | Hospitalization, surgery |
| Retroperitoneal bleed | ICU admission, transfusions |
| Intracranial bleed | Stroke, permanent disability |
| Internal organ bleed | Emergency surgery |
The delayed detection of internal bleeding makes these cases particularly strong. Patients often had no external signs until the situation became critical.
Medical experts for the plaintiffs argue the drug’s mechanism increases this risk. Factor Xa inhibition can prevent normal clotting throughout the body.
Eliquis Lawsuit Compensation
Eliquis lawsuit compensation covers several categories of damages. Plaintiffs can seek payment for medical bills, lost wages, and pain and suffering.
Economic damages include hospital stays, surgeries, and rehabilitation costs. These are relatively straightforward to calculate with billing records.
Non-economic damages cover emotional distress and reduced quality of life. These amounts are more subjective and vary by jurisdiction.
- Medical expenses: Past and future treatment costs
- Lost income: Wages missed during recovery
- Pain and suffering: Physical and emotional toll
- Loss of consortium: Impact on family relationships
- Punitive damages: Possible if corporate misconduct is proven
Punitive damages could significantly increase total compensation. These are awarded when a jury finds the company acted with reckless disregard.
Some state laws cap non-economic damages in medical product cases. Your claim value will depend partly on where your case is filed.
Key Takeaway: Compensation covers medical bills, lost wages, pain and suffering, and potentially punitive damages for corporate misconduct.
Eliquis MDL Lawsuit
The eliquis MDL lawsuit is consolidated under MDL No. 2754 in federal court. This means most federal cases are grouped together for efficiency.
MDL consolidation allows one judge to handle pretrial matters for all cases. It speeds up discovery and avoids conflicting rulings across districts.
The Southern District of New York was chosen as the MDL venue. This is where Bristol Myers Squibb maintains its headquarters.
| MDL Detail | Information |
|---|---|
| MDL Number | 2754 |
| Court | SDNY |
| Presiding Judge | Denise Cote |
| Cases Consolidated | Over 10,000 |
| Status | Pretrial and bellwether prep |
MDL does not mean your case becomes a class action. Each plaintiff retains their individual claim and potential settlement.
If bellwether trials produce large verdicts, it often accelerates global settlement talks. A string of defense wins could slow the process down.
Eliquis Lawsuit Bristol Myers Squibb
The eliquis lawsuit Bristol Myers Squibb connection is central to the case. BMS co-developed and co-markets Eliquis with Pfizer.
Bristol Myers Squibb is the primary defendant in most filings. The company holds the New Drug Application for Eliquis with the FDA.
Plaintiffs allege BMS had early clinical trial data showing bleeding risks. They claim this data was not shared with prescribing physicians.
- BMS reported over $12 billion in Eliquis revenue in 2023
- The drug is the company’s top-selling product
- Patent protections extend through the late 2020s
- BMS has denied all liability in court filings
Pfizer shares marketing responsibilities in the United States. Both companies are named defendants in the majority of complaints.
The financial stakes are enormous for both corporations. A large global settlement could cost billions of dollars.
Key Takeaway: Bristol Myers Squibb is the primary defendant, and Eliquis is its highest-revenue drug, making this a high-stakes case.
How to File Eliquis Lawsuit
Learning how to file an Eliquis lawsuit starts with gathering your medical records. You need documentation proving you took the drug and suffered harm.
The next step is finding a law firm that handles pharmaceutical litigation. Most firms work on contingency, meaning no upfront fees.
Your attorney will review your case and determine which court to file in. Federal MDL cases and state court cases follow different procedures.
- Step 1: Collect all medical records related to Eliquis use
- Step 2: Document your bleeding event and treatment
- Step 3: Contact a pharmaceutical injury law firm
- Step 4: Complete a claim evaluation questionnaire
- Step 5: Your attorney files the complaint in the appropriate court
The entire filing process typically takes a few weeks once you have your records. The legal team handles the paperwork and court submissions.
You do not need to appear in court during the early stages. Most of the process happens through document exchanges and attorney negotiations.
Eliquis Hemorrhagic Stroke Lawsuit
The eliquis hemorrhagic stroke lawsuit involves the most catastrophic injury claims. A hemorrhagic stroke occurs when a blood vessel in the brain ruptures.
Blood thinners like Eliquis can make these strokes more likely and more severe. The drug prevents clotting, which worsens brain bleeding once it starts.
Plaintiffs in these cases often suffer permanent disability. Many require round-the-clock care for the rest of their lives.
| Stroke Outcome | Impact on Claim Value |
|---|---|
| Full recovery | Lower settlement tier |
| Partial disability | Mid-range settlement |
| Permanent disability | High settlement tier |
| Fatal stroke | Wrongful death tier |
These cases carry the highest potential compensation amounts. Lifetime care costs alone can exceed several million dollars.
Neurologists frequently testify as expert witnesses in these trials. They explain how anticoagulation therapy amplified the stroke damage.
Eliquis Reversal Agent Lawsuit
The eliquis reversal agent lawsuit adds a unique angle to the litigation. For years, Eliquis had no FDA-approved antidote for bleeding emergencies.
Doctors could not quickly reverse the drug’s effects during a crisis. This contrasted sharply with warfarin, which has vitamin K as an antidote.
The FDA approved Andexxa (andexanet alfa) in 2018 as a reversal agent. However, plaintiffs argue the years without an antidote caused preventable deaths.
- 2012 to 2018: No approved reversal agent existed
- 2018: FDA approved Andexxa for Eliquis reversal
- 2019 to present: Andexxa availability remains limited at many hospitals
- Cost: A single dose of Andexxa can exceed $50,000
Plaintiffs argue the companies should have developed an antidote sooner. They also point out that many hospitals still cannot access Andexxa.
This reversal agent issue strengthens the failure-to-warn claims. It shows patients were put at risk without a safety net for emergencies.
Key Takeaway: The six-year gap without a reversal agent is a major argument in the Eliquis litigation.
Frequently Asked Questions
How much is the average Eliquis lawsuit settlement in 2026?
Most claims are estimated between $25,000 and $500,000 depending on injury severity.
Wrongful death and permanent disability cases sit at the higher end of that range.
No global settlement has been finalized yet, so these figures remain projections.
Who qualifies to file an Eliquis lawsuit?
You qualify if you took Eliquis and suffered a documented bleeding injury.
Most eligible patients used the drug between 2012 and 2024.
Medical records proving the injury are required to support your claim.
Is there a deadline to file an Eliquis claim?
Yes, the deadline depends on your state’s statute of limitations.
Most states allow two to four years from the date of your injury.
Some states use a discovery rule that may extend your filing window.
What injuries are covered by the Eliquis blood thinner lawsuit?
The lawsuit covers gastrointestinal bleeding, intracranial hemorrhage, and stroke.
Retroperitoneal bleeding and other internal hemorrhagic events also qualify.
Any severe bleeding event linked to Eliquis use may support a claim.
Is the Eliquis MDL still accepting new cases?
Yes, MDL No. 2754 is still accepting new case transfers as of 2026.
The court continues to consolidate eligible claims from federal districts nationwide.
Filing sooner is better because deadlines may tighten as bellwether trials begin.
The Eliquis litigation is at a turning point in 2026. Bellwether trials and settlement negotiations could reshape the entire case this year.
If you took Eliquis and suffered a bleeding event, check your eligibility now. Gather your medical records and get your claim evaluated before deadlines pass.
Stay informed as new developments emerge in the coming months. The outcome of these trials will affect thousands of patients nationwide.
